(11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid

CAS: 745-65-3

Ref. AN-AG0038GD

Produktinformation

• Name: (11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
• Synonyme: [u'Alprostadil', u'Caverject', u'Edex', u'Lipo PGE1', u'Lipo-PGE1', u'Minprog', u'Muse', u'PGE1', u'PGE1alpha', u'Prostaglandin E1', u'Prostaglandin E1alpha', u'Prostavasin', u'Prostin VR', u'Prostine VR', u'Sugiran', u'Vasaprostan', u'Viridal', u'alprostadil', u'Prostaglandin E1', u'745-65-3', u'PGE1', u'Caverject', u'Edex', u'Muse', u'Prostin VR', u'Alprostadilum', u'Femprox', u'Befar', u'Liprostin', u'Prostandin', u'Vitaros', u'PGE-1', u'Befar (TN)', u'Prink (TN)', u'Prostavasin', u'Topiglan', u'Vasaprostan', u'Alprostadil(Caverject)', u'Alprox-TD', u'Prostaglandin-E1', u'l-Prostaglandin E1', u'MR-256', u'Minprog', u'UNII-F5TD010360', u'(11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid', u'CHEMBL495', u'Prostin VR Pediatric', u'Lipoprost', u'Prostivas', u'Alista', u'Prink', u'11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid', u'(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate', u'CHEBI:15544', u'PGE1alpha', u'9-oxo-11R,15S-dihydroxy-13E-prostaenoic acid', u'GMVPRGQOIOIIMI-DWKJAMRDSA-N', u'U-10136', u'7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid', u'F5TD010360', u'(-)-Protaglandin E1', u'Sugiran', u'Viridal', u'(13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid', u'l-PGE1', u'Alprostadilum [INN-Latin]', u'PGE1 Oligomer', u'7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid', u'Alprostadil Prostoglandin E1', u'Promostan', u'FemLife', u'ONO 1608', u'EINECS 212-017-2', u'RayVa', u'Prostaglandine E', u'Caverject Impulse', u'NSC 165559', u'7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid', u'7-[(1r,3r)-3-Hydroxy-2-[(1e,3s)-3-Hydroxyoct-1-En-1-Yl]-5-Oxocyclopentyl]heptanoic Acid', u'CPD000112594', u'SMR000112594', u'AI3-62116', u'U 10136', u'SR-01000597593', u'MR 256', u'Prostin VR pediatric (TN)', u'BML1-F06', u'3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid', u'l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid', u'Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-', u'Alprostadil(usan)', u'HEI-507', u'(1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid', u'NCGC00016535-01', u'119314-69-1', u'CAS-745-65-3', u'Vitaros (TN)', u'(13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoate', u'Alprostadil [USAN:USP:INN:BAN:JAN]', u'AC1NQXHQ', u'11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid', u'PGE1;Prostaglandin E1', u'Prestwick2_001018', u'Prestwick3_001018', u'U-10,136', u'DSSTox_CID_2578', u'Prostaglandin E1, 98+%', u'DSSTox_RID_76640', u'DSSTox_GSID_22578', u'SCHEMBL33317', u'BSPBio_001175', u'BSPBio_001488', u'MLS000758964', u'MLS001424250', u'BIDD:GT0747', u'BPBio1_001293', u'GTPL1882', u'Alprostadil (JP17/USP/INN)', u'Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, l-', u'DTXSID9022578', u'PGE1, Prostaglandin E1, powder', u'SYN3025', u'HMS1361K10', u'HMS1571K17', u'HMS1791K10', u'HMS1989K10', u'HMS2052L11', u'HMS2090L08', u'HMS2098K17', u'HMS3268I09', u'HMS3402K10', u'HMS3648O17', u'HMS3678N07', u'HMS3715K17', u'(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid', u'BCP01740', u'EX-A1411', u'HY-B0131', u'ZINC3813088', u'Tox21_110482'], (-)-Prostaglandin E₁, (11alpha,12xi,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid, (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oate, (11alpha,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid, 11,15-Dihydroxy-9-Oxoprost-13-En-1-Oic Acid, 11α,15(S)-Dihydroxy-9-oxo-13-trans-prostenoic acid, 11α,15α-Dihydroxy-9-oxo-13-trans-prostenoic acid, Aiprostadil, Alprostadil, Alprostan, Alprox TD, Caveject, Caverject, Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, (-)-, Cyclopentaneheptanoic acid, 3α-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, Eglandin, Liple, Lipo PGE1, Lipoprost, Liprostin, Minprog, Nsc 165559, Ono 1608, PGE₁, Palux, Pge1, Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11α,13E,15S)-, Prostandin, Prostandin 500, Prostin VR Pediatric, Prostivas, SEPA-alprostadil, SEPA-prostaglandin E1, Sepa-Pge1, Topiglan, U 10136, Vasaprostan, l-PGE1, l-PGE₁, l-Prostaglandin E1, l-Prostaglandin E₁, prostandin E1
• CAS: 745-65-3
• Marke: Indagoo

Chemische Eigenschaften

• Molekulargewicht: 354.4810
• Formel: C₂₀H₃₄O₅
• Reinheit: 98%
• Farbe/Form: Solid
• InChl: InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,19+/m0/s1
• InChI Key: GMVPRGQOIOIIMI-DWKJAMRDSA-N